• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1996年至2015年期间澳大利亚癌症发病率和死亡率的变化。

Changes in cancer incidence and mortality in Australia over the period 1996-2015.

作者信息

Luo Qingwei, Steinberg Julia, O'Connell Dianne L, Grogan Paul B, Canfell Karen, Feletto Eleonora

机构信息

Cancer Research Division, Cancer Council NSW, Kings Cross, PO Box 572, Sydney, NSW, 1340, Australia.

The University of Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.

出版信息

BMC Res Notes. 2020 Dec 10;13(1):561. doi: 10.1186/s13104-020-05395-6.

DOI:10.1186/s13104-020-05395-6
PMID:33303018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7726606/
Abstract

OBJECTIVE

A previous Australian study compared the observed numbers of cancer cases and deaths in 2007 with the expected numbers based on 1987 rates. This study examines the impact of cancer rate changes over the 20-year period 1996-2015, for people aged under 75 years.

RESULTS

The overall age-standardised cancer incidence rate increased from 350.7 in 1995 to 364.4 per 100,000 in 2015. Over the period 1996-2015, there were 29,226 (2.0%) more cases (males: 5940, 0.7%; females: 23,286, 3.7%) than expected numbers based on 1995 rates. Smaller numbers of cases were observed compared to those expected for cancers of the lung for males and colorectum, and cancers with unknown primary. Larger numbers of cases were observed compared to those expected for cancers of the prostate, thyroid and female breast. The overall age-standardised cancer mortality rate decreased from 125.6 in 1995 to 84.3 per 100,000 in 2015. During 1996 to 2015 there were 106,903 (- 20.6%) fewer cancer deaths (males: - 69,007, - 22.6%; females: - 37,896, - 17.9%) than expected based on the 1995 mortality rates. Smaller numbers of deaths were observed compared to those expected for cancers of the lung, colorectum and female breast, and more cancer deaths were observed for liver cancer.

摘要

目的

澳大利亚此前的一项研究将2007年观察到的癌症病例数和死亡数与基于1987年发病率的预期数进行了比较。本研究考察了1996 - 2015年这20年间癌症发病率变化对75岁以下人群的影响。

结果

总体年龄标准化癌症发病率从1995年的每10万人350.7例增至2015年的364.4例。在1996 - 2015年期间,实际病例数比基于1995年发病率预期的病例数多29226例(2.0%)(男性:5940例,0.7%;女性:23286例,3.7%)。观察到的男性肺癌、结直肠癌以及原发灶不明癌症的病例数低于预期。观察到的前列腺癌、甲状腺癌和女性乳腺癌病例数高于预期。总体年龄标准化癌症死亡率从1995年的每10万人125.6例降至2015年的84.3例。在1996至2015年期间,癌症死亡人数比基于1995年死亡率预期的死亡人数少106903例(-20.6%)(男性:-69007例,-22.6%;女性:-37896例,-17.9%)。观察到的肺癌、结直肠癌和女性乳腺癌死亡人数低于预期,而肝癌的癌症死亡人数高于预期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7663/7727166/6a486815ec3e/13104_2020_5395_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7663/7727166/6a486815ec3e/13104_2020_5395_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7663/7727166/6a486815ec3e/13104_2020_5395_Fig1_HTML.jpg

相似文献

1
Changes in cancer incidence and mortality in Australia over the period 1996-2015.1996年至2015年期间澳大利亚癌症发病率和死亡率的变化。
BMC Res Notes. 2020 Dec 10;13(1):561. doi: 10.1186/s13104-020-05395-6.
2
Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007.75 岁以下人群的癌症发病率和死亡率:1987-2007 年期间澳大利亚的变化。
Cancer Epidemiol. 2013 Dec;37(6):780-7. doi: 10.1016/j.canep.2013.09.010. Epub 2013 Oct 30.
3
Comparison of cancer mortality and incidence in New Zealand and Australia.新西兰和澳大利亚癌症死亡率与发病率的比较。
N Z Med J. 2002 May 10;115(1153):205-8.
4
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
5
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].[国家重点污染场地居民流行病学研究。第六次报告]
Epidemiol Prev. 2023 Jan-Apr;47(1-2 Suppl 1):1-286. doi: 10.19191/EP23.1-2-S1.003.
6
Cancer in Australia: actual incidence and mortality data from 1982 to 2007 and projections to 2010.澳大利亚的癌症情况:1982年至2007年的实际发病率和死亡率数据以及至2010年的预测
Asia Pac J Clin Oncol. 2011 Dec;7(4):325-38. doi: 10.1111/j.1743-7563.2011.01502.x.
7
Comparison of Cancer Mortality and Incidence Between New Zealand and Australia and Reflection on Differences in Cancer Care: An Ecological Cross-Sectional Study of 2014-2018.新西兰和澳大利亚的癌症死亡率和发病率比较以及对癌症护理差异的反思:2014-2018 年的生态交叉横断面研究。
Cancer Control. 2023 Jan-Dec;30:10732748231152330. doi: 10.1177/10732748231152330.
8
Cancer mortality and incidence trends comparing New Zealand and Australia for the period 2000-2007.2000 - 2007年期间新西兰与澳大利亚癌症死亡率和发病率趋势比较
N Z Med J. 2014 Aug 15;127(1400):9-19.
9
Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017.澳大利亚的癌症情况:1982年至2013年的实际发病率数据以及1982年至2014年的死亡率数据,并预测至2017年。
Asia Pac J Clin Oncol. 2018 Feb;14(1):5-15. doi: 10.1111/ajco.12761. Epub 2017 Sep 20.
10
[Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy].[意大利撒丁岛工业、采矿或军事基地所在地区居民健康状况报告]
Epidemiol Prev. 2006 Jan-Feb;30(1 Suppl 1):5-95.

引用本文的文献

1
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.新冠疫情是否延迟了局部乳腺癌患者的治疗?一项多中心研究。
PLoS One. 2024 May 31;19(5):e0304556. doi: 10.1371/journal.pone.0304556. eCollection 2024.
2
Trends and projections of cause-specific premature mortality in Australia to 2044: a statistical modelling study.到2044年澳大利亚特定病因过早死亡的趋势与预测:一项统计建模研究
Lancet Reg Health West Pac. 2024 Jan 5;43:100987. doi: 10.1016/j.lanwpc.2023.100987. eCollection 2024 Feb.
3
Identifying cancer driver genes in individual tumours.

本文引用的文献

1
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.一种逆阶段转移模型,用于估计因 COVID-19 大流行而延迟获得癌症服务对超额死亡率和健康经济的影响。
Asia Pac J Clin Oncol. 2021 Aug;17(4):359-367. doi: 10.1111/ajco.13505. Epub 2021 Feb 10.
2
Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control?二十一世纪澳大利亚的肺癌死亡率:通过有效的烟草控制可以挽救多少生命?
Lung Cancer. 2019 Apr;130:208-215. doi: 10.1016/j.lungcan.2019.02.028. Epub 2019 Feb 28.
3
识别个体肿瘤中的癌症驱动基因。
Comput Struct Biotechnol J. 2023 Oct 13;21:5028-5038. doi: 10.1016/j.csbj.2023.10.019. eCollection 2023.
4
Projections of smoking-related cancer mortality in Australia to 2044.到2044年澳大利亚与吸烟相关的癌症死亡率预测。
J Epidemiol Community Health. 2022 Jun 24;76(9):792-9. doi: 10.1136/jech-2021-218252.
5
Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.2020 年至 2044 年澳大利亚的癌症发病率和死亡率,以及对 COVID-19 大流行期间治疗延迟潜在影响的探索性分析:一项统计建模研究。
Lancet Public Health. 2022 Jun;7(6):e537-e548. doi: 10.1016/S2468-2667(22)00090-1.
Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.
澳大利亚前列腺癌过度诊断的终身风险:使用新的终身风险方法定量评估澳大利亚前列腺癌筛查相关的过度诊断风险。
BMJ Open. 2019 Mar 10;9(3):e022457. doi: 10.1136/bmjopen-2018-022457.
4
Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases.澳大利亚 1982 年至 2014 年结肠癌和直肠癌发病率趋势:超过 37.5 万例数据分析。
Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):83-90. doi: 10.1158/1055-9965.EPI-18-0523. Epub 2018 Dec 7.
5
Uterine Cancer Incidence and Mortality - United States, 1999-2016.美国 1999-2016 年子宫癌发病率和死亡率。
MMWR Morb Mortal Wkly Rep. 2018 Dec 7;67(48):1333-1338. doi: 10.15585/mmwr.mm6748a1.
6
Lung cancer mortality in Australia: Projected outcomes to 2040.澳大利亚肺癌死亡率:2040 年预测结果。
Lung Cancer. 2018 Nov;125:68-76. doi: 10.1016/j.lungcan.2018.09.001. Epub 2018 Sep 8.
7
The projected timeframe until cervical cancer elimination in Australia: a modelling study.澳大利亚消除宫颈癌的预计时间框架:建模研究。
Lancet Public Health. 2019 Jan;4(1):e19-e27. doi: 10.1016/S2468-2667(18)30183-X. Epub 2018 Oct 2.
8
Dermoscopy and Overdiagnosis of Melanoma In Situ.皮肤镜检查与原位黑色素瘤的过度诊断
JAMA Dermatol. 2018 Apr 1;154(4):398-399. doi: 10.1001/jamadermatol.2017.6448.
9
Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.澳大利亚国家结直肠癌筛查计划的长期获益、危害和成本效益的评估:一项建模研究。
Lancet Public Health. 2017 Jul;2(7):e331-e340. doi: 10.1016/S2468-2667(17)30105-6. Epub 2017 Jun 26.
10
Impact of the Australian National Cervical Screening Program in women of different ages.澳大利亚国家宫颈癌筛查计划对不同年龄女性的影响。
Med J Aust. 2016 Oct 17;205(8):359-364. doi: 10.5694/mja16.00289.